
A phase I study of MN-029 (denibulin), a novel vascular-disrupting agent, in patients with advanced solid tumors
Alejandro D. Ricart, Edward A. Ashton, Matthew M. Cooney, John Sarantopoulos, Joanna M. Brell, Maria A. Feldman, Kale E. Ruby, Kazuko Matsuda, Mark S. Munsey, Gerardo Medina, Angela Zambito, Anthony WVolume:
68
Langue:
english
Pages:
12
DOI:
10.1007/s00280-011-1565-4
Date:
October, 2011
Fichier:
PDF, 1.73 MB
english, 2011